immune response phenotype
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (21)
Papers in which this entity is mentioned.
- Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
- Chromosomal instability as a driver of cancer progression. (2025)
- Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
- ENPP1 Immunobiology as a Therapeutic Target. (2023)
- Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. (2023)
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- RNA splicing dysregulation and the hallmarks of cancer. (2023)
- Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
- HSP70 and HSP90 in neurodegenerative diseases. (2020)
- The Immune Landscape of Cancer. (2018)
- Predicting T cell recognition of MHC class I restricted neoepitopes. (2018)
- Thymic involution and rising disease incidence with age. (2018)
- Fast and accurate HLA typing from short-read next-generation sequence data with xHLA. (2017)
- Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
- Gene-environment interactions in development and disease. (2017)
- Effects of alcohol on the endocrine system. (2013)
- Properties of MHC class I presented peptides that enhance immunogenicity. (2013)
- An integrated encyclopedia of DNA elements in the human genome. (2012)
- An integrated ChIP-seq analysis platform with customizable workflows. (2011)
- The HLA system: genetics, immunology, clinical testing, and clinical implications. (2007)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| immune response | phenotype | 48 | 68 |